Factors associated with pre-treatment HIV RNA: Application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings

• Main Authors: Sasisopin Kiertiburanakul, David Boettiger, Oon Tek Ng, Nguyen Kinh, Tuti Parwati Merati, Anchalee Avihingsanon, Wing Wai Wong, Man Po Lee, Romanee Chaiwarith, Adeeba Kamarulzaman, Pacharee Kantipong, Fujie Zhang, Jun Yong Choi, Nagalingeswaran Kumarasamy, Rossana Ditangco, Do Duy Cuong, Shinichi Oka, Benedict Lim Heng Sim, Winai Ratanasuwan, Penh Sun Ly, Evy Yunihastuti, Sanjay Pujari, Jeremy L. Ross, Matthew Law, Somnuek Sungkanuparph, V. Khol, F. J. Zhang, H. X. Zhao, N. Han, P. C.K. Li, W. Lam, Y. T. Chan, S. Saghayam, C. Ezhilarasi, K. Joshi, S. Gaikwad, A. Chitalikar, D. N. Wirawan, F. Yuliana, D. Imran, A. Widhani, J. Tanuma, T. Nishijima, S. Na, J. M. Kim, Y. M. Gani, R. David, S. F. Syed Omar, S. Ponnampalavanar, I. Azwa, E. Uy, R. Bantique, W. W. Ku, P. C. Wu, P. L. Lim, L. S. Lee, P. S. Ohnmar, S. Gatechompol, P. Phanuphak, C. Phadungphon, L. Chumla, N. Sanmeema, T. Sirisanthana, W. Kotarathititum, J. Praparattanapan, P. Kambua, R. Sriondee, K. V. Nguyen, H. V. Bui, D. T.H. Nguyen, D. T. Nguyen, N. V. An, N. T. Luan, A. H. Sohn, B. Petersen, D. A. Cooper, A. Jiamsakul, D. C. Boettiger
• Other Authors: Mahidol University
• Format: Article
• Published: 2018
• Subjects: Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/41907

© 2017 The Author(s). Background: Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïve HIV-infected patients. However, both drugs are only recommended for the patients who have pre-treatment HIV RNA <100,000 copies/mL. In resource-limited settings, pre-treatment HIV R...